Enable job alerts via email!

Director, Financial Planning & Analysis

Alnylam Pharmaceuticals

Cambridge

Hybrid

GBP 90,000 - 130,000

Full time

Today
Be an early applicant

Boost your interview chances

Create a job specific, tailored resume for higher success rate.

Job summary

A leading company in RNA interference therapeutics is seeking a Director of R&D Financial Planning & Analysis. This hybrid role involves strategic financial support for global development programs, collaboration with various teams, and the development of financial dashboards. Ideal candidates will have extensive experience in finance and the biotech industry, along with strong interpersonal skills.

Qualifications

  • 10+ years of experience in FP&A, accounting, or strategic finance.
  • 6+ years of biotech/pharma industry R&D experience.
  • Ability to manage risks and opportunities in finance.

Responsibilities

  • Serve as financial representative on global development teams.
  • Provide strategic financial support for business case reviews.
  • Develop program financial dashboards and support budgeting.

Skills

Financial valuation methodologies
Interpersonal skills
Attention to detail
Client-service orientation

Education

Bachelor's Degree in Finance or related field
MBA (preferred)

Job description

This role is considered Hybrid.

Overview

Reporting to the Head of R&D Finance, the Director of R&D Financial Planning & Analysis is a key member of Alnylam's Finance team. This role will work closely with business leaders at all levels of the organization and will be focused on providing strategic financial support to the company's global development program teams.

This position is hybrid and will be primarily located in Cambridge, MA.

Key Responsibilities

  1. Serve as the financial representative on global development program teams, working closely with Program Leaders, Program Managers, and functional experts. Offer guidance and support from a financial perspective while proactively managing potential risks and opportunities in alignment with Finance leadership.
  2. Provide strategic financial support (e.g., NPVs, IRR) for business case reviews to facilitate decision-making by executive leadership. Present findings to program teams and senior leadership as appropriate.
  3. Develop a new program financial dashboard in partnership with stakeholders across Finance and the business, summarizing financial and operational status and other key data points.
  4. Support annual budgeting and long-range planning by aligning key assumptions between program teams and functional leadership, ensuring financial submissions are aligned.
  5. Collaborate with R&D Finance, CMC Finance, and Alliance Finance teams to understand variances between actual results and budgets/forecasts. Review variance analyses with leadership and recommend adjustments as needed.
  6. Assist in developing budgets for external partners in collaboration with the Alliance Finance team.
  7. Build strong relationships within the broader Finance organization and support special projects and ad hoc analyses as needed.
  8. Support the growth and development of junior team members in R&D Finance.

Qualifications

  • Bachelor's Degree in Finance or related quantitative field (e.g., Statistics, Econometrics, Mathematics). Advanced degrees like an MBA are preferred.
  • 10+ years of experience in FP&A, accounting, valuation, or strategic finance roles.
  • 6+ years of biotech/pharma industry R&D experience.
  • Strong knowledge of financial valuation methodologies used in biotech/pharma.
  • Ability to switch between strategic discussions and operational tasks within a matrixed organization.
  • Excellent interpersonal skills and ability to work effectively across functions and seniority levels.
  • High level of integrity, accuracy, and attention to detail.
  • Positive, flexible, and client-service-oriented attitude towards business teams.

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has pioneered RNA interference (RNAi) therapeutics, transforming scientific discovery into innovative medicines for rare and common diseases. Founded in 2002, Alnylam continues to lead the RNAi revolution, turning science into reality.

Our culture: Our people-first culture is driven by core values: innovation, openness, urgency, excellence, and commitment. Recognized globally as a top employer, we prioritize inclusivity, belonging, and empowering employees to bring their authentic selves to work, fostering groundbreaking medical advances.

Get your free, confidential resume review.
or drag and drop a PDF, DOC, DOCX, ODT, or PAGES file up to 5MB.

Similar jobs

Head of Financial Planning Analysis

Aila Recruitment | Certified B Corporation

Letchworth

Hybrid

GBP 80,000 - 120,000

Today
Be an early applicant

FP&A Manager

JR United Kingdom

City of Edinburgh

Remote

GBP 60,000 - 100,000

14 days ago

Audit and Regulatory Due Diligence Advisor (Private Equity Acquisition)

ReachX

Remote

GBP 80,000 - 100,000

Yesterday
Be an early applicant

FP&A Manager

Thermo Fisher Scientific

Remote

USD 100,000 - 130,000

30+ days ago

Head of Financial Planning Analysis

ZipRecruiter

Letchworth

Hybrid

GBP 90,000 - 100,000

22 days ago

Head of Financial Planning Analysis

JR United Kingdom

Letchworth

On-site

GBP 60,000 - 100,000

25 days ago

Transformation & FP&A Lead Milton Keynes Morgan McKinley Full time

Morgan McKinley

Milton Keynes

On-site

GBP 100,000 - 120,000

4 days ago
Be an early applicant

Compliance Director - Financial Planning

IDEX Consulting Ltd

Remote

GBP 80,000 - 120,000

22 days ago

Head of Financial Planning & Analysis

Altro Ltd

Letchworth

Hybrid

GBP 60,000 - 100,000

30+ days ago